SÍNDROME NEUROLÉPTICA MALIGNA EM PACIENTE EM USO DE OLANZAPINA – RELATO DE CASO

Autor: Mendonça, Sandro Bichara, Mendonça, Gabriel Soares, Quitete, Marcela, Range, Carolina Cassiano, Bravin, Débora Moreira

Publikováno v: Scientific Journal of the Medical School of Campos; Vol. 11 No. 1 (2016); 26-29
Revista Científica da Faculdade de Medicina de Campos; v. 11 n. 1 (2016); 26-29
Revista Científica da Faculdade de Medicina de Campos
Faculdade de Medicina de Campos (FMC)
instacron:FMC

Introduction: Neuroleptic Malignant Syndrome (NMS) is a major complication of the use of antipsychotics, relatively rare, but potentially fatal, and can lead to death in 10-20 % of cases.1-5. This syndrome is characterized by severe muscle stiffness

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3056::677fdec45e4ce646359032a6e83bf92c
https://www.fmc.br/ojs/index.php/RCFMC/article/view/14